June 29th, 2023

Accolade, Inc. (Nasdaq: ACCD) released its first-quarter fiscal 2024 earnings report, revealing a loss of $0.52 per share, which was better than the consensus estimate of a loss of $0.62 per share. The company also reported quarterly sales of $93.20 . Read more

June 29th, 2023

Employee and friend traded ahead of Pfizer’s “game-changer” announcement on the success of its Paxlovid trial FOR IMMEDIATE RELEASE 2022-123 Washington D.C. / CRWE PRESS RELEASE / June 29, 2023 -  The Securities and Exch. Read more

June 29th, 2023

Shares of BioXcel Therapeutics, Inc.? (Nasdaq: BTAI) plunged by over 50% in premarket trading following the company's disclosure of a regulatory inquiry into the development of BXCL501, as revealed in a regulatory filing with the SEC. Despite this. Read more

June 29th, 2023

Shares of Joby Aviation, Inc. (NYSE: JOBY) experienced a significant surge of over 10% in pre-market trading following the announcement of an equity investment by SK Telecom Co., Ltd.? (NYSE: SKM), a prominent telecommunications company in South Kore. Read more

June 29th, 2023

Shares of BlackBerry Limited (NYSE: BB) experienced a significant surge of over 10% in pre-market trading following the release of better-than-expected financial results. The company delivered a surprise profit for the first quarter of fiscal 2024. Read more

June 29th, 2023

ZoomInfo Technologies Inc. (Nasdaq: ZI), a leading provider of go-to-market intelligence solutions, received coverage initiation from Needham with a Buy rating and a price target of $35.  Despite closing at $25.61 on Wednesday, the stated pri. Read more

June 28th, 2023

Silver Spring, MD / CRWE PRESS RELEASE / June 28, 2023 -  Today, the U.S. Food and Drug Administration approved Lantidra, the first allogeneic (donor) pancreatic islet cellular therapy made from deceased donor pancreatic cells for the treat. Read more

June 28th, 2023

Biopharmaceutical leader Gilead Sciences, Inc. (Nasdaq: GILD) has disclosed its acquisition of 2,930,870 shares of AlloVir, Inc. (Nasdaq: ALVR), a late clinical-stage cell therapy company, in a regulatory filing FORM 4 with the SEC. The shares were a. Read more

June 28th, 2023

Shares of Micron Technology, Inc. (Nasdaq: MU) surged in after-hours trading following the release of its better-than-expected financial results. In the third quarter of fiscal 2023, Micron reported a loss of $1.43 per share and revenue of $3.752 . Read more

June 28th, 2023

General Mills, Inc. (NYSE: GIS) released its fourth-quarter fiscal 2023 earnings report, surpassing the consensus estimates for earnings per share (EPS).  The company reported an EPS of $1.12, exceeding the consensus of $1.07. However, its sa. Read more